Acknowledgement
Supported by : Chungbuk National University
References
- Crowley WF Jr, Comite F, Vale W, Rivier J, Loriaux DL, Cutler GB Jr. Therapeutic use of pituitary desensitization with a long-acting LHRH agonist : a potential new treatment for idiopathic precocious puberty. J Clin Endocrinol Metab 1981; 52:370-2 https://doi.org/10.1210/jcem-52-2-370
- Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med 1994;45:391-405 https://doi.org/10.1146/annurev.med.45.1.391
- Carrel AL, Allen DB. Effects of growth hormone on body composition and bone metabolism. Endocrine 2000;12:163- 72 https://doi.org/10.1385/ENDO:12:2:163
- Saggese G, Bertelloni S, Baroncelli GI, Battini R, Franchi G. Reduction of bone mineral density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 1993;152:712-20 https://doi.org/10.1007/BF01953981
- Bertelloni S, Baroncelli GI, Sorrentino MC, Perri G, Saggese G. Effect of central precocious puberty and gonadotropin-releasing hormone analogue treatment on peak bone mass and final height in females. Eur J Pediatr 1998;157:363-7 https://doi.org/10.1007/s004310050831
- Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Tato L. Bone development during GH and GnRH analog treatment. Eur J Endocrinol 2004;151:S47-S54 https://doi.org/10.1530/eje.0.151S047
- Gleulich WW, Pyle SI. Radiographic atlas of skeletal development of the hand and wrist. 2nd ed. California : Stanford University Press, 1971
- Barden HS, Wacker WK, Faulkner KG, GE Healthcare. Pediatric DXA enhancements: variable standard deviations, total body skull exclusion. Annual meeting of International Society for Clinical Densitometry; 2005 Feb; New Orleans. Available from: URL://http://www.iscd.org/Visitors/conferences/index 05.cfm
- Lim JS, Hwang JS, Park KD, Lee JA, Kim DH, Cheon GJ, et al. Bone mineral density according to age, bone age, and pubertal stages in Korean children and adolescents. J Clin Densitom 2009; in press https://doi.org/10.1016/j.jocd.2009.09.006
- Gordon CL, Holton JM, Atkinson SA, Webber CE. The contributions of growth and puberty to peak bone mass. Growth Dev Aging 1991;55:257-62
- Lu PW, Briody JN, Ogle GD, Morley K, Humphries IR, Allen J, et al. Bone mineral density of total body, spine and femoral neck in children and young adults: a cross sectional and longitudinal study. J Bone Miner Res 1994;9:1451-8 https://doi.org/10.1002/jbmr.5650090918
- Finkelstein JS, Neer RM, Biller BM, Crawford JD, Klibanski A. Osteopenia in men with a history of delayed puberty. N Engl J Med 1992;326:600-4 https://doi.org/10.1056/NEJM199202273260904
- Constantini NW, Warren MP. Special problems of the female athlete. Baillieres Clin Rheumatol 1994;8:199-19 https://doi.org/10.1016/S0950-3579(05)80232-8
- Parfitt AM. The two faces of growth: benefits and risks to bone integrity. Osteoporos Int 1994;4:382-98 https://doi.org/10.1007/BF01622201
- Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, et al. Bone mineral metabolism in girls with precocious puberty during gonadotropin releasing hormone agonist treatment. Eur J Endocrinol 1995;133:412-7 https://doi.org/10.1530/eje.0.1330412
- Ruiz JC, Mandel C, Garabedian M. Influence of spontaneous calcium intake and physical exercise on the vertebral and femoral bone mineral density of children and adolescents. J Bone Miner Res 1995;10:675-82 https://doi.org/10.1002/jbmr.5650100502
- Johnston CC Jr, Miller JZ, Siemenda CW, Rester TK, Hui S, Christian JC, Peacock M. Calcium supplementation and increase in bone mineral density in children. N Engl J Med 1992;327:82-7 https://doi.org/10.1056/NEJM199207093270204
- Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Mengarda F, Pietrobelli A, et al. Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. J Clin Endocrinol Metab 2003;88:1096-101 https://doi.org/10.1210/jc.2002-021154
- Pasquino AM, Pucarelli I, Accardo F, Demiraj V, Segni M, Di Nardo R. Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: Impact on adult height, body mass index, bone mineral content and reproductive function. J Clin Endocrinol Metab 2008;93:190-5 https://doi.org/10.1210/jc.2007-1216
- Saggese G, Federico G, Barsanti S, Cerri S. Is there a place for combined therapy with GnRH agonist plus growth hormone in improving final height in short statured children? J Pediatr Endocrinol Metab 2000;13 Suppl 1:821-6
- Saggese G, Federico G, Barsanti S, Fiore L. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated GH deficiency: results from a controlled study. J Clin Endocrinol Metab 2001;86:1900-4 https://doi.org/10.1210/jc.86.5.1900
- Lanes R. Growth velocity, final height and bone mineral metabolism of short children treated long term with growth hormone. Curr Pharm Biotechnol 2000;1:33-46 https://doi.org/10.2174/1389201003378997
- Lanes R, Gunczler P, Esaa S, Weisinger JR. The effect of short- and long-term growth hormone treatment on bone mineral density and bone metabolism of prepubertal children with idiopathic short stature: a 3-year study. Clin Endocrinol 2002;57:725-30 https://doi.org/10.1046/j.1365-2265.2002.01614.x
- Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G. Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues. Eur J Pediatr 2000;159:369-74 https://doi.org/10.1007/s004310051289